We serve N-Ethyl-p-Toluenesulfonamide CAS:80-39-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
| Items of Analysis | Standard of Analysis | Test Results |
| Appearance | White crystalline particles or powder | Conform |
| Assay | ≥99% | 99.63% |
| Moisture | ≤0.5% | 0.12% |
| Melting point | ≥58℃ | 59.2℃ |
| Ash | ≤0.1% | 0.05% |
| Conclusion | Conforms to Factory Standard | |
Contact us for information like N-Ethyl-p-Toluenesulfonamide chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzenesulfonamide, N-ethyl-4-methyl- physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-ethyl-4-methylbenzenesulfonamide Use and application,Benzenesulfonamide, N-ethyl-4-methyl- technical grade,usp/ep/jp grade.
Related News: Process: The importance of safety is obvious. The research and development of specialty drug substances (especially high-barrier generic drug substance drugs) usually need to avoid the original process patents, and some chemicals are developed because of the complex structure or the harsh synthetic conditions The synthetic route is more difficult, so the importance of process design capabilities of API companies is becoming more important.L-arginyl-L-leucyl-L-histidyl-L-tyrosyl-L-leucyl-L-phenylalanine manufacturer Australia has started denying entry to all travelers who have come from or transited through mainland China.2-(3,4-dichloro-phenyl)-3-(2-methoxy-ethyl)-1-oxo-1λ4-thiazolidin-4-one supplier Catalent’s clinical supply network includes nine cGMP-certified clinical packaging facilities across North America, Europe and Asia, and more than 50 strategically-located depots around the world, providing local and regional options for clinical storage, distribution, expiry update and relabeling services, and clinical returns management.trichloro-bis(2,3,4,5,6-pentafluorophenyl)-λ(sup)5(/sup)-phosphane vendor With the improvement of domestic GMP management level, the increase of process development capabilities and international certification experience, China has already possessed the conditions for developing characteristic APIs.Commonly used generic drugs: the products whose patents have expired and the generic drugs of many companies have participated in the competition, and the market demand is large.
